Committed to Improving Lives Through Health Science
IMMUSE™ is distributed by Kyowa Hakko USA, a recent winner of the Frost & Sullivan 2021 North American New Product Innovator Award for its strong scientific research, stringent quality standards and clear commitment to regulatory guidelines.
Pioneers in the development and application of patented fermentation technology, Kyowa Hakko is a part of the Kirin group, one of the largest beverage and pharmaceutical holding companies in Japan and around the globe widely recognized as a leader in fermentation for over 110 years.
For more than 60 years, Kyowa has maintained a constant commitment to research, innovation and quality. With Kyowa's commitment to improving lives through health science, IMMUSE™ has been the subject of 30 studies, and clinically shown to activate pDCs for proactive immune support at the cellular level.
More about the Award